Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12328193 | 1.00 | ATM (0.53) | ATMGAAMMEACE | |
| SCHEMBL8271333 | 1.00 | ATM (0.53) | ATMGAAMMEACE | |
| SCHEMBL13614138 | 1.00 | ATM (0.53) | ATMGAAMMEACE | |
| SCHEMBL24141939 | 0.80 | ATM (0.38) | ATM | |
| SCHEMBL18924818 | 0.80 | ATM (0.42) | ATMGAA | |
| SCHEMBL12901426 | 0.80 | ATM (0.47) | ATM | |
| SCHEMBL19901587 | 0.77 | ATM (0.35) | ATM | |
| SCHEMBL19901586 | 0.77 | ATM (0.35) | ATM | |
| SCHEMBL8089409 | 0.77 | ATM (0.36) | ATM | |
| SCHEMBL28153658 | 0.76 | ATM (0.57) | ATMGAAMMEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1231213-B1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI (IT) | 2004-08-11 | — | — | EP | claimed |
| US-6635456-B2 | Generation of preferential phosphatides; obtain phosphatide, incubate with phosphatidyl glycerol, incubate phospholipase, recover phosphatide | FIDIA FARMACEUTICI S.P.A. (IT) | 2003-10-21 | — | — | US | claimed |
| US-20020155558-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.P.A. (IT) | 2002-10-24 | — | — | US | claimed |
| WO-2002064603-A1 | PROCEDURE FOR THE PREPARATION OF PURE PHOSPHATIDES AND THEIR USE IN THE COSMETIC, PHARMACEUTICAL AND ALIMENTARY FIELDS | FIDIA FARMACEUTICI S.P.A. (IT) | 2002-08-22 | — | — | WO | claimed |
| EP-1231213-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.p.A. (IT) | 2002-08-14 | — | — | EP | claimed |
| US-5554728-A | Lipid conjugates of therapeutic peptides and protease inhibitors | NEXSTAR PHARMACEUTICALS, INC. (US) | 1996-09-10 | — | — | US | claimed |
| EP-0596024-A4 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS. | VESTAR INC (US) | 1996-07-17 | — | — | EP | claimed |
| EP-0596024-A1 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS | NeXstar Pharmaceuticals, Inc. (US) | 1994-05-11 | — | — | EP | claimed |
| WO-1993001828-A1 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS | VICAL, INC. (US) | 1993-02-04 | — | — | WO | claimed |
| EP-1231213-B1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI (IT) | 2004-08-11 | — | — | EP | disclosed |
| US-20040053376-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.P.A. | 2004-03-18 | — | — | US | disclosed |
| US-6635456-B2 | Generation of preferential phosphatides; obtain phosphatide, incubate with phosphatidyl glycerol, incubate phospholipase, recover phosphatide | FIDIA FARMACEUTICI S.P.A. (IT) | 2003-10-21 | — | — | US | disclosed |
| US-20020155558-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.P.A. (IT) | 2002-10-24 | — | — | US | disclosed |
| WO-2002064603-A1 | PROCEDURE FOR THE PREPARATION OF PURE PHOSPHATIDES AND THEIR USE IN THE COSMETIC, PHARMACEUTICAL AND ALIMENTARY FIELDS | FIDIA FARMACEUTICI S.P.A. (IT) | 2002-08-22 | — | — | WO | disclosed |
| EP-1231213-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.p.A. (IT) | 2002-08-14 | — | — | EP | disclosed |
| US-5804552-A | COMPOUND CONSISTING OF TYROSINE OR HYDROXYPROLINE LINKED TO PHOSPHOLIPID BY PHOSPHOESTER BOND THROUGH HYDROXYL GROUP; CAPABLE OF CONJUGATION WITH THERAPEUTIC PEPTIDE | NEXSTAR PHARMACEUTICALS, INC. (US) | 1998-09-08 | — | — | US | disclosed |
| US-5554728-A | Lipid conjugates of therapeutic peptides and protease inhibitors | NEXSTAR PHARMACEUTICALS, INC. (US) | 1996-09-10 | — | — | US | disclosed |
| EP-0596024-A4 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS. | VESTAR INC (US) | 1996-07-17 | — | — | EP | disclosed |
| EP-0596024-A1 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS | NeXstar Pharmaceuticals, Inc. (US) | 1994-05-11 | — | — | EP | disclosed |
| WO-1993001828-A1 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS | VICAL, INC. (US) | 1993-02-04 | — | — | WO | disclosed |